4//SEC Filing
Gilliam Joseph E 4
Accession 0001415889-24-030120
CIK 0001192448other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 9:15 PM ET
Size
15.9 KB
Accession
0001415889-24-030120
Insider Transaction Report
Form 4
GLAUKOS CorpGKOS
Gilliam Joseph E
PRESIDENT & COO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-12-20−1,053→ 0 totalExercise: $39.10Exp: 2030-03-12→ Common Stock (1,053 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-12-20−2,275→ 431 totalExercise: $69.30Exp: 2029-03-14→ Common Stock (2,275 underlying) - Exercise/Conversion
Common Stock
2024-12-20$69.30/sh+2,275$157,658→ 105,497 total - Sale
Common Stock
2024-12-20$150.35/sh−1,292$194,252→ 102,169 total - Sale
Common Stock
2024-12-20$149.54/sh−2,036$304,463→ 103,461 total - Exercise/Conversion
Common Stock
2024-12-20$39.10/sh+1,053$41,172→ 103,222 total
Footnotes (7)
- [F1]Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person, and includes 324 shares of common stock of the Issuer that were purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024.
- [F3]This transaction was executed in multiple trades at prices ranging from $149.01 to $149.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $150.03 to $150.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024.
- [F6]This option was granted on March 12, 2020 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.
- [F7]This option was granted on March 14, 2019 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.
Documents
Issuer
GLAUKOS Corp
CIK 0001192448
Entity typeother
Related Parties
1- filerCIK 0001705850
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 9:15 PM ET
- Size
- 15.9 KB